OR WAIT null SECS
July 27, 2018
The recommended drugs include two orphan medicines and three biosimilars.
July 19, 2018
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
July 18, 2018
AbbVie will grant Mylan license to launch a biosimilar to AbbVie’s Humira.
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
The media, by Tosoh Bioscience, is composed of calcium and phosphate buffers and offers mixed-mode properties for biomolecule purification.
July 12, 2018
The agency is releasing six new draft guidances to provide a regulatory framework for handling gene therapies.
July 11, 2018
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
July 09, 2018
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
July 03, 2018
Biogen will pay Samsung BioLogics approximately $700 million to increase its stake in Samsung Bioepis to approximately 49.9%.
